Novartis NVS Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	117.45B	112.24B	110.98B	112.7B	99.95B	94.33B	97.51B	103.52B
Total Current Assets	36.91B	32.11B	33.49B	45.66B	30.48B	26.45B	25.69B	31.26B
Cash and Equivalents	7.52B	12B	10.89B	12.41B	13.39B	9.47B	7.9B	13.61B
Total Non-Current Assets	89.88B	78.62B	76.03B	65.74B	77.57B	66.55B	70.44B	70.81B
Total Liabilities	58.03B	60.1B	59.05B	74.45B	53.2B	54.58B	55.6B	60.08B
Total Current Liabilities	28.66B	30.55B	31.91B	48.39B	26.39B	29.29B	27.61B	28.13B
Total Non-Current Liabilities	51.16B	51.54B	46.94B	45.58B	46.84B	44.01B	49.21B	57.3B
Common Equity	890M	842M	842M	825M	825M	793M	793M	793M
Retained Earnings	63.54B	56.09B	55.68B	42.33B	49.65B	43.83B	45.84B	46.29B

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Assets	130.12B	133.08B	145.56B	118.37B	132.06B	131.8B	117.45B	99.95B
Total Current Assets	24.93B	28.21B	35.56B	29.5B	29.67B	45.72B	36.91B	30.48B
Cash and Equivalents	7.01B	8.86B	13.27B	11.11B	9.66B	12.41B	7.52B	13.39B
Total Non-Current Assets	74.89B	74.23B	78.69B	55.55B	56.67B	67.82B	59.42B	46.75B
Total Liabilities	55.23B	58.85B	66.87B	62.82B	75.39B	63.97B	58.03B	53.2B
Total Current Liabilities	22.21B	23.4B	29.61B	28.26B	33.06B	30.21B	28.66B	26.39B
Total Non-Current Liabilities	50.92B	58.67B	59.73B	56.61B	70.31B	58.29B	51.16B	46.84B
Total Equity	74.89B	74.23B	78.69B	55.55B	56.67B	67.82B	59.42B	46.75B
Common Equity	972M	969M	944M	936M	913M	901M	890M	825M
Retained Earnings	73.94B	73.3B	82.19B	59.28B	57.16B	70.99B	63.54B	49.65B